Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.
Saved in:
| Title: | Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response. |
|---|---|
| Authors: | Choi H; Department of Oncology, Georgetown University, Washington, DC., Kwon J; Department of Oncology, Georgetown University, Washington, DC., Cho MS; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sun Y; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana., Zheng X; Department of Bioinformatics and Statistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang J; Department of Bioinformatics and Statistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bouker KB; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC., Casey JL; Department of Microorganism and Immunology, Georgetown University School of Medicine, Washington, DC., Atkins MB; Department of Oncology, Georgetown University, Washington, DC.; Division of Hematology/Oncology MedStar Georgetown University Hospital, Washington, DC., Toretsky J; Department of Oncology, Georgetown University, Washington, DC.; Department of Pediatrics, Georgetown University School of Medicine, Washington, DC., Han C; Department of Oncology, Georgetown University, Washington, DC. ch1182@georgetown.edu. |
| Source: | Cancer research [Cancer Res] 2021 Jul 01; Vol. 81 (13), pp. 3607-3620. Date of Electronic Publication: 2021 May 03. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
